Search results
Found 1080 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Single cell spatial analysis provides new insight into immune-pathology in Covid-19 lungs
Coronavirus COVID-19 General Research
9 November 2023
A Nature Communications study led by Professor Ling-Pei Ho’s group in the MRC Translational Immune Discovery Unit (TIDU) provides new insights into how immune cells interact in the lungs of patients with severe COVID-19.
New discovery furthers our understanding of how critical immune cells are controlled during an infection
General Research
9 November 2023
A recent publication from Research from the Gerard Lab in Kennedy Institute of Rheumatology looks at how a specific protein, called IFNγ, can coordinate CD8+ T cell responses during a flu infection.
Partnership with Danaher paves way for precision medicine test for sepsis
General Research
8 November 2023
The University of Oxford today announced a partnership with Danaher Corporation to develop a new test to enable precision medicine care for sepsis, a pathological immune response to infection that accounts for one in five deaths globally each year.
Prof Anna Schuh launches first private specialised haematology clinic and laboratory in sub-Saharan Africa
General Innovation Research
6 November 2023
SerenOx Africa aims to address diagnostic gaps for common blood disorders through a testing facility for key underserved patient populations in Tanzania. This facility will also aim to provide early cancer detection for high-risk patients.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
General Research
6 November 2023
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, while also looking to improve manufacturing speed and scale-up of ChAdOx technology. Learnings could be leveraged to inform vaccine design for related viruses from the Arenavirus family, giving the world a head start in rapidly responding to future outbreaks in as little as 100 days. First project to be initiated under CEPI and University of Oxford’s strategic partnership to accelerate global pandemic preparedness efforts.
RECOVERY trial expands to investigate treatments for influenza
Coronavirus COVID-19 General Research
31 October 2023
The RECOVERY trial, which discovered four effective treatments for COVID-19, has expanded to investigate treatments for influenza (flu).
First digital atlas of human fetal brain development published
General Research
25 October 2023
The first digital atlas showing how the human brain develops in the womb has been published by a global research team led by the University of Oxford.
Estimating hospital-acquired SARS-CoV-2 infections in England
General Research
23 October 2023
An estimated 95,000–167,000 inpatients at English National Health Service (NHS) hospitals caught SARS-CoV-2 while in hospital during England’s ‘second wave’ of COVID-19, between June 2020 and March 2021, reports a study in Nature. The findings reveal the scale of hospital transmissions and highlight contributing factors, such as a limited number of single rooms.
New AI tool could help predict viral outbreaks
General Innovation Research
19 October 2023
As the COVID-19 pandemic demonstrated, viruses can quickly evolve new ways of evading our immune systems, undermining our efforts to control outbreaks. But a new artificial intelligence (AI) tool developed by researchers at the University of Oxford and Harvard Medical School could help predict new viral variants before they emerge. The findings have been published in the journal Nature.
Tackling mental illness by supporting industry to develop new drugs
General Innovation Research
11 October 2023
An academic/industry partnership, based at the NIHR Oxford Health Biomedical Research Centre, is helping companies use experimental medicine approaches to speed up development of new drugs to treat psychiatric disorders.
The Big Shot. Oxford, Africa and the R21 malaria vaccine
General Research
11 October 2023
What we desperately need are new tools to improve malaria control, and this is the first vaccine that can be deployed at scale, that will be affordable, and can be used widely in Africa on a scale of hundreds of millions of doses each year.
Oxford to lead global collaboration to research and develop next-generation COVID-19 and flu vaccines
Coronavirus COVID-19 General Research
11 October 2023
Project headed by Oxford University’s Professor Teresa Lambe OBE (Calleva Head of Vaccinology and Immunology, Department of Paediatrics) and co-developer of the Oxford/AstraZeneca COVID-19 vaccine and Paul Klenerman (Sidney Truelove Professor, Nuffield Department of Medicine)
Wearable sensors provide early detection of progression in Parkinson’s Disease
General Innovation Research
11 October 2023
A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson’s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
Professor Alan Bernstein appointed as new University of Oxford Director of Global Health
General Research
10 October 2023
Professor Alan Bernstein has been appointed as the new head of Oxford Global Health, which will bring together and showcase the breadth of global health research across the University of Oxford.
New research finds that reducing antibiotic usage in animal feed is not enough to combat antibiotic resistance
General Research
6 October 2023
A new study led by the University of Oxford has found that natural evolution of antibiotic resistance genes has maintained resistance in bacteria despite a reduction in the use of antibiotics. The findings demonstrate the importance of understanding the regulatory evolution of resistance genes to strategically combat AMR. The study has been published in the Journal of the International Society for Microbial Ecology (ISME).
Gene therapy opens new possibilities for treating chronic pain
General Research
6 October 2023
Researchers from the Nuffield Department of Clinical Neurosciences at the University of Oxford, along with colleagues at Cambridge University and Barts and the London School of Medicine and Dentistry, have shown the potential of a new gene therapy approach to silence human sensory neurons (nerve cells) as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
Oxford researchers develop 3D printing method that shows promise for repairing brain injuries
General Innovation Research
5 October 2023
A breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer brain injuries. The researchers demonstrated for the first time that neural cells can be 3D printed to mimic the architecture of the cerebral cortex. These results have been published today in the journal Nature Communications.
The long road to a new malaria vaccine, told by the scientists behind the breakthrough – podcast
General Research
4 October 2023
Oxford-Harrington Rare Disease Centre launches pioneering Therapeutics Accelerator to advance inovative treatments for rare diseases
General Innovation Research
3 October 2023
The University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio announced the launch of the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator with an official signing event at the University of Oxford. The event was hosted by the Oxford-Harrington Rare Disease Centre (OHC), a partnership established in 2019 between the University of Oxford and Harrington Discovery Institute. Attendance at the signing included leaders from OHC, the University of Oxford, the Harrington family, University Hospitals, and Oxford Science Enterprises.
New research endoscopy service launches today
General Research
2 October 2023
The launch of a new endoscopy service at the Oxford Experimental Medicine Clinical Research Facility (EMCRF) will enhance the collection of data for research projects at the Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) and across the University of Oxford.